Technetium Tc-99m pertechnetate is a radiocontrast agent used for the identification of various organs, including but not limited to the brain, thyroid, placenta, and bladder. Technetium Tc-99m pertechnetate is a radiopharmaceutical diagnostic agent composed of an oxoanion with the chemical formula TcO4-.
- Mechanism
- Curator reviewed
The pertechnetate ion distributes in the body similarly to the iodide ion, but is not organified when trapped in the thyroid gland. It also concentrates in the thyroid gland, salivary glands, gastric mucosa, and choroid plexus. However, in contrast to the iodide ion, the pertechnetate ion is released unchanged from the thyroid gland.
- Primary indication
- Sodium Pertechnetate Tc99m Injection is indicated for use in adults for imaging in the following tissues: thyroid, salivary gland, urinary bladder (for detection of vesico-ureteral reflux), and nasolacrimal drainage system (dacryoscintigraphy).Curator reviewed · 4 structured indications
- Formula / weight
- H8O4Tc · 169.968 g/mol (avg)
- First approval
- Canada, 2020 · United States, 1975
- Also known as
- (99Tc)pertechnetate · CPERT · GPERT · Pertechnetate-99Tc · Technetium (99mTc) Pertechnetate
Resolves to
ZTFPRNKAHXDALS-RCUQKECRSA-NSMILESO.O.O.O.[98Tc-]What you can answer from here — as of August 30, 2026
Which other approved drugs treat the same conditions as Technetium Tc-99m pertechnetate, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account